Trial Profile
A Phase II Trial With the HIV Protease Inhibitor Indinavir for the Treatment of Classical Kaposi's Sarcoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2011
Price :
$35
*
At a glance
- Drugs Indinavir (Primary)
- Indications Kaposi's sarcoma
- Focus Therapeutic Use
- 17 Nov 2006 New trial record.